NCT02028312 A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® Status WITHDRAWN Phase PHASE4
NCT01743729 A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye Status COMPLETED Phase PHASE3
NCT01664949 A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease Status COMPLETED Phase PHASE3
NCT01478555 A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease Status WITHDRAWN Phase PHASE2
NCT01468168 A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients Status COMPLETED Phase PHASE2
NCT01421498 Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1) Status COMPLETED Phase PHASE3
NCT01276223 Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients Status COMPLETED Phase PHASE2
NCT01014078 A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease Status COMPLETED Phase PHASE4
NCT00831662 The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637) Status COMPLETED Phase PHASE3
NCT00827255 Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05% Status COMPLETED Phase N/A
NCT00799682 Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® Status COMPLETED Phase PHASE4
NCT00760045 Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time Status COMPLETED Phase PHASE2
NCT00758784 Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease Status COMPLETED Phase PHASE2